OBR was first established in Oxford in July of 2011 as a forum to help facilitate the interaction between industry and academics. After growing out of term to over 500 members, OBR evolved quickly and expanded to Cambridge and London in autumn of 2011, though many of its core leadership team still remain in Oxford. OBR has many strong partnerships with industry and academic organisations in Oxford, regularly holding events in the department of biochemistry and Saïd business school at the University of Oxford. Please contact the chapter president Peter Crane for enquiries regarding industry partnerships and joining the OBR-Oxford team.
Peter is a 3rd year DPhil student in Chemical Biology at the Chemical Research Laboratory, Oxford. His work focusses upon the chemical modification of proteins, by site-specific methodologies, for biophysics, immunology and glycobiology. His interests lie not only in the natural sciences, but extend to the societal impact of disruptive technologies and science investment.
Sophia is a 1st year DPhil student, on a Clarendon Scholarship, at the department of Physiology, Anatomy & Genetics of University of Oxford. Her research focuses on cardiovascular regeneration using cardiac stem cells. In addition to research, she is interested in entrepreneurship and scientific innovations.
Justin is a research assistant in the Schermelleh Lab at the Department of Biochemistry. A University of Chicago graduate, Justin's focus is on applications of super-resolution light microscopy, using structured illumination to visualize biological processes below the 200nm diffraction limit. He is interested in finding new ways to apply advanced imaging to the commercial biotech space
Jon is a final year visiting PhD student at the Weatherall Institute for Molecular Medicine, Oxford. His thesis investigates the production of blood stem cells with a view to their therapeutic use in leukemia treatment. Beyond the lab bench Jon’s passions lie in translating novel science into new treatments and diagnostic techniques to address medical needs. Jon is happiest when the Aussies are winning at cricket and the Spurs at football.
Ivan is currently a chemistry undergrad, specializing in chemistry at the interface with pharma, biotech and nanotech.
Susan is studying for a PhD in Healthcare Innovation within the Institute of Biomedical Engineering. Susan researches drug targeting to reduce side effects. Currently she is looking at the ways to use ultrasound to release drugs from nanoparticles at a tumour site.
Jack is going into his 4th year at Oxford studying towards a Masters in Molecular and Cellular Biochemistry. His main interests include the elucidation of the changes in the epigenetic code underlying cancer onset and progression as well as the application of this understanding to drug design and development.
Professor Hagan Bayley PhD, FRSC, FRS
Prof Bayley is the Professor of Chemical Biology at the University of Oxford. He enjoys working at the interface of chemistry and biology by, for example, developing techniques for protein modification that have applications in both basic science and biotechnology. Professor Bayley founded Oxford Nanopore Technology, which spun from the University of Oxford in 2005. To date, the Company has raised nearly £75 million in six rounds of private funding, from a combination of private and institutional investors.
Professor Sir John Bell FRS, FMedSci
Professor Bell went to Oxford as a Rhodes Scholar to train in medicine and undertook postgraduate training in London and at Stanford University. Professor Bell was Academy President from 2006-2011 and is now Regius Professor of Medicine at Oxford University.
Professor Graham Richards C.B.E, MA, D.Phil, D.Sc., C.Chem, FRSC
Prof Graham Richards is a former Head of Chemistry at the University of Oxford and a council member at both the Royal Society of Chemistry & the Royal Institution. He has authored 300 scientific articles & 15 books, and has been recognized with numerous awards, including the Mullard Award, Lord Lloyd of Kilgerran Prize, the Italgas Prize & the Award of the American Chemical Society for Computers in Chemical and Pharmaceutical Research. His business ventures include co-founding Oxford Molecular, and helping to establish Oxford’s technology transfer office, Isis Innovations.
Dr Marc Ventresca
Dr Marc Ventresca is an organisational and economic sociologist who teaches strategy, leadership and organisation theory at Oxford’s Saïd Business School with a focus on innovation and on how new markets get built. He also works as Senior Scholar with Center for Innovation and Communication at Stanford University. Marc holds a lead faculty role in research and teaching initiatives focused on innovation and entrepreneurship. His research investigates governance innovation among global financial markets, entrepreneurial leadership in knowledge- and information-intensive organisations, and value creation in emerging ecosystem services markets.
The Entrepreneurship Centre is the focal point for entrepreneurship research, teaching and practice at the University of Oxford. The Centre brings together academics, spinout- and student-entrepreneurs, for the study and practice of entrepreneurship and is the doorway to the over 2,000 high-tech companies in and around Oxford. Its programmes and events combine research on and practical teaching of entrepreneurship to support entrepreneurs and high-growth companies. Students on the MBA and the Executive MBA have access to a broad range of electives, project work, a venture fund, student societies, such as Oxford Entrepreneurs, and open programmes to build up their understanding of entrepreneurship and innovation whilst studying at Saïd Business School. Many MBA entrepreneurship projects evolve into successful new ventures, and Saïd Business School alumni companies now number over 150. About one in ten of the School’s MBAs leaves to set up a new venture upon graduation and the Centre has created a vibrant community of entrepreneurs and spin-outs connected to the School that enriches our offerings for students and outside firms alike.
The Medical Sciences Division is an internationally recognized centre of excellence for biomedical and clinical research and teaching with a reputation for delivering world-leading research programmes with global impact. We are the largest academic division in the University of Oxford with over 2200 academics and staff, 800 graduate students and 900 undergraduates. Together with the Oxford University Hospitals we host the Oxford Biomedical Research Centre funded by the National Institutes for Health Research. The Division is committed to translational research for patient benefit and has a history of successful partnerships with industry, academia, medical organisations and charities. For more information please visit http://www.medsci.ox.ac.uk/.
The George Institute for Global Health, UK, is based within the Nuffield Department of Population Health of the Medical Sciences Division at the University of Oxford. The establishment of the Institute has been made possible by the generosity of Dr James Martin, whose donation to the University led to the development of the Oxford Martin School, of which the Institute is a member. The George Institute’s programme of research and development focuses on the health priorities of emerging economies, such as China and India, as well as resource poor areas of developed countries. The Institute has three unique programmes of work: healthcare innovation, the development of affordable health technologies and is the lead organisation of the Oxford-India Health Research Network. Much of the Institute’s work is aimed at providing evidence that will directly inform policy and practice.
Anna was a PhD student in the Nuffield Department of Medicine, University of Oxford where she worked on the potential of human pluripotent stem cells to form blood. Anna lead OBR’s Oxford chapter for the 2012-13 academic year. Her interests are in the commercialisation of scientific research and the promotion of innovation.
Melissa is a OXION Wellcome Trust Training fellow in the Department of Physiology, Anatomy and Genetics. She works in diabetes on the effect of hyperglycaemia on alpha and beta cell function. Melissa obtained her PhD from The University of Manchester where she investigated the expression and function of potassium channels in human placental vascular smooth muscle.
Łukasz Stasiak is a DPhil student in Physiology, Anatomy and Genetics at Oxford, where he is a recipient of a Wellcome Trust 4 year scholarship. He studies FTO – a fat mass and obesity associated gene. Previously, Łukasz completed a masters with a specialization in Molecular Biotechnology and Technical Biochemistry.
Serena completed a DPhil student and is now a Post-Doc at the Gray Institute for Radiation, Oncology and Biology. She is interested in understanding the role of the tumour microenvironment in tumour progression. Previously, she received a MSc in Medical Biotechnology from the University of Turin. She is interested in translating medical research from the bench to the bedside.
Vanessa Restrepo Schild
Vanessa is a student researcher of Chemical Biology within the Chemical Research Laboratory, Oxford. Her work focusses upon the development of droplet networks, from equipment design and manufacture to the modification of the membrane components. Her interests are in biotechnology for new technology development.